Australia markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.06+0.22 (+4.55%)
At close: 04:00PM EDT
5.08 +0.02 (+0.40%)
After hours: 07:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.84
Open4.91
Bid5.03 x 300
Ask5.06 x 400
Day's range4.80 - 5.11
52-week range4.48 - 10.45
Volume916,016
Avg. volume1,487,775
Market cap415.489M
Beta (5Y monthly)0.58
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    12 $10 Stocks That Will Triple

    In this article, we discuss 12 $10 stocks that will triple. If you want to skip our discussion on the latest stock market landscape, head over to 5 $10 Stocks That Will Triple. According to JPMorgan, the global outlook for securities markets in 2024 suggests a more positive scenario compared to the previous year, with […]

  • Insider Monkey

    Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript

    Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript February 7, 2024 Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.0001, expectations were $-0.14. AVXL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. Welcome to […]

  • Zacks

    Vertex's (VRTX) Non-Opioid Pain Drug Meets Primary Goal

    Three late-stage studies data show that Vertex's (VRTX) experimental non-opioid drug reduced pain across a 48-hour period. Based on this data, VRTX intends to submit an FDA filing by mid-2024.